Trials / Completed
CompletedNCT05279469
D-Dimer as Predictor of Disease Outcome in Intensive Care Unit in COVID-19m Patients
D-Dimer as Predictor of Disease Outcome in Intensive Care Unit in SARS-COV-2 Patients: A Retrospective Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 465 (actual)
- Sponsor
- Ain Shams University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
Evaluating value of D-Dimer blood level of icu admitted patients on admission and 48 hours later as outcome predictor in SARS.COV.2 patients.
Detailed description
Evaluating value of D-Dimer blood level of icu admitted patients on admission and 48 hours later as outcome predictor in SARS.COV.2 patients. It has been reported that COVID 19 is associated with hemostatic abnormalities and elevated D-Dimer level, so its level is used to predict severity of disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | no intervention, just observational for D-Dimer level in blood | observation for basal D-Dimer and 48 hours later D-Dimer in blood for ICU SARS.COV.2 patients |
Timeline
- Start date
- 2021-06-10
- Primary completion
- 2022-03-03
- Completion
- 2022-03-09
- First posted
- 2022-03-15
- Last updated
- 2022-03-15
Locations
2 sites across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05279469. Inclusion in this directory is not an endorsement.